Similarly, genetic deletion of the Adora2b receptor in mouse and human triple-negative breast cancer cells reduces their metastatic capability in vivo (109), suggesting an important role for Adora2b in cancer metastasis. The gene discussed is ADORA2B; the disease is triple-negative breast carcinoma.